David Juurlink (/ˈjʊərlɪŋk/ YURE-link;[2] born New Glasgow, Nova Scotia) is a Canadian pharmacologist and internist. He is head of the Clinical Pharmacology and Toxicology division at Sunnybrook Health Sciences Centre in Toronto, Ontario, as well as a medical toxicologist at the Ontario Poison Centre and a scientist at the Institute for Clinical Evaluative Sciences. He is known for researching adverse effects caused by drug interactions, with some of this research funded by a New Investigator Award from the Canadian Institutes for Health Research.[3] He has been very critical of his fellow physicians' regular prescribing of dangerous opioids like Tramadol[4] and fentanyl.[5][6] In June 2017, he published a letter analyzing citations to "Addiction Rare in Patients Treated with Narcotics", a 1980 letter in The New England Journal of Medicine that has often been cited to claim that opioids like OxyContin are rarely addictive.[7]
David Juurlink | |
---|---|
Born | 1968 (age 55–56) New Glasgow, Nova Scotia, Canada |
Alma mater | Dalhousie University[1] |
Occupation | Physician |
References
edit- ^ "David Juurlink". Retrieved 26 October 2020.
- ^ "Meet the Expert Video Series featuring ICES senior scientist Dr. David Juurlink". YouTube. June 2, 2015. Retrieved 29 November 2022.
- ^ "We are Sunnybrook". The Globe and Mail. 7 May 2011. Retrieved 24 June 2017.
- ^ Kirkup, Kristy (26 February 2017). "Health Canada's position on opioid Tramadol is indefensible: doctor". The Globe and Mail. Retrieved 24 June 2017.
- ^ Kirkey, Sharon (7 April 2016). "Doctors' reckless prescribing of fentanyl largely to blame for deadly overdoses: expert". National Post. Retrieved 24 June 2017.
- ^ "Dr. David Juurlink says colleagues must accept blame for fentanyl ODs". CBC News. 24 August 2015. Retrieved 24 June 2017.
- ^ "Opioid crisis: The letter that started it all". BBC News. 3 June 2017. Retrieved 24 June 2017.
External links
edit- David Juurlink Profile
- David Juurlink publications indexed by Google Scholar